Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2019-07-04 Major Shareholding Noti…
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
PR_2019-07-04_BT_Transparency Notification-JReymann_EN_Final.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled "Transparency notification received from Mr. J. Reymann" and explicitly references "Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings." It details the passive crossing of the 5% shareholding threshold by an individual, Mr. J. Reymann, and provides specific figures for voting rights before and after the crossing. This content directly relates to insider transactions or significant changes in share ownership, which aligns perfectly with the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the notification is about a major shareholder crossing a threshold, MRQ (Major Shareholding Notification) is the most precise fit, as DIRS usually refers to transactions by directors/executives, whereas this is a major shareholder notification based on a specific legal threshold crossing.
2019-07-04 English
PR_2019-07-04_BT_Transparency Notification-JReymann_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Notification de transparence reçue de la part de M. J. Reymann" (Transparency notification received from Mr. J. Reymann) and explicitly references "Article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes" (Article 14, paragraph 1 of the law of May 2, 2007, concerning the disclosure of significant shareholdings). It details the crossing of a 5% ownership threshold by an individual shareholder (M. J. Reymann) following a private placement. This content directly corresponds to the reporting of personal share transactions by executives or major shareholders crossing notification thresholds, which aligns perfectly with the definition for Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the core content is the notification of a change in significant share ownership (crossing the 5% threshold), MRQ (Major Shareholding Notification) is the most precise fit, although DIRS often covers similar insider activity. Given the explicit mention of crossing a significant ownership threshold (5%), MRQ is selected over DIRS, which typically focuses on director transactions rather than general significant shareholder notifications, although there is overlap. However, looking at the provided definitions, DIRS is for 'Report of personal share transactions by company directors and executives (insider trades)', while MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document is explicitly about crossing a threshold, making MRQ the best fit.
2019-07-04 French
PR_2019-07-02_BT_ABB2019 Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information on the total number of voting rights and shares" and is dated 2 July 2019. It explicitly states that the information is published in accordance with Article 15 of the Belgian Law regarding the publication of major shareholdings. The core content details the change in the total number of shares with voting rights following a recent issuance of new shares via an accelerated bookbuild offering. This type of announcement, which reports on changes in the total number of shares outstanding (the denominator for EPS calculations and voting rights), is a specific corporate action disclosure. While it relates to capital structure, it is most precisely categorized as a notification regarding share changes, which aligns best with 'Share Issue/Capital Change' (SHA) or potentially a general 'Regulatory Filing' (RNS). Given the specific focus on the total number of voting rights and shares following an issuance, SHA is the most appropriate fit, as it directly concerns the share count and capital structure update.
2019-07-02 English
PR_2019-07-02_BT_ABB2019 Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions" (Information relating to the total number of voting rights and shares) and is dated July 2, 2019. It explicitly details the change in the total number of shares and voting rights following a private placement completed on June 27, 2019. This type of mandatory disclosure, which reports changes in the total share capital and voting rights denominator, is typically classified as a notification related to share capital changes or major shareholding changes, depending on the specific jurisdiction's requirements. Given the options, this announcement directly concerns the structure of the company's shares and voting power resulting from a financing event (private placement). While it relates to capital, the core focus is the resulting share count. The closest fit among the provided codes is 'SHA' (Share Issue/Capital Change) or potentially 'MRQ' (Major Shareholding Notification) if it were crossing a threshold, but since it details the *result* of a new share issue, SHA is more appropriate. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a proxy statement (PSI) or director dealing (DIRS). It is a direct announcement of a capital structure change via new share issuance.
2019-07-02 French
20190626_Rapport_spécial BoD.pdf
Share Issue/Capital Change Classification · 95% confidence The document is titled "RAPPORT SPECIAL DU CONSEIL D'ADMINISTRATION ETABLI CONFORMEMENT AUX ARTICLES 7:198 JUNCTO 7:191 et 7:193 DU CODE DES SOCIETES ET DES ASSOCIATIONS" (Special Report of the Board of Directors established in accordance with Articles 7:198 juncto 7:191 and 7:193 of the Companies and Associations Code). This report specifically details a proposal by the Board of Directors to cancel the pre-emptive rights of existing shareholders concerning a proposed capital increase via a private placement reserved for qualified investors. This content strongly aligns with documents detailing corporate governance, board proposals regarding capital structure, and compliance with specific corporate law articles related to shareholder rights and capital changes. While it discusses a capital change (CAP) and involves the Board (MANG), the primary function of this specific legal document is to provide the required justification and information to shareholders regarding the proposed capital structure change and the suppression of pre-emptive rights, which falls under the scope of corporate governance and specific legal reporting requirements for such actions. Given the detailed legal framework cited (Articles 7:198, 7:191, 7:193 of the Belgian Code), it is a formal report detailing governance practices related to capital changes. However, since the core subject is the proposal to change the capital structure (issuing new shares via private placement and cancelling pre-emptive rights), the most fitting category is Capital/Financing Update (CAP), as it is the detailed report justifying this specific financing action, rather than just a general governance report (CGR) or a simple announcement of a share issue (SHA). Since it is a comprehensive report detailing the structure, justification, and legal basis for a major financing event, it is classified as CAP, although it has strong elements of CGR/LTR due to the legal citations.
2019-06-27 French
Bone Therapeutics successfully raises EUR 8.5 million
Capital/Financing Update Classification · 99% confidence The document is explicitly titled "PRESS RELEASE REGULATED INFORMATION - INSIDE INFORMATION" and details the successful raising of EUR 8.5 million through a private placement of new shares and a subordinated bond issuance. This activity directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). The document is a full announcement, not just a notice of publication, and its content is focused on the financing details, not general earnings or annual performance.
2019-06-27 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.